Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Medical Genetics and Applied Genomics, |
RCV001267936 | SCV001446453 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, |
RCV001644964 | SCV001519097 | likely pathogenic | Autosomal recessive spinocerebellar ataxia 10 | 2021-07-12 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001267936 | SCV004292684 | pathogenic | not provided | 2024-01-30 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 337 of the ANO10 protein (p.Phe337Val). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This missense change has been observed in individuals with spinocerebellar ataxia (PMID: 25089919, 27045840, 34445196). ClinVar contains an entry for this variant (Variation ID: 986820). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ANO10 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects ANO10 function (PMID: 32620747). For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV001267936 | SCV004700074 | likely pathogenic | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | ANO10: PM3:Strong, PM2 |